Lyon,
France
18 May 2019 - 21 May 2019
ea0063s10.1 | Cancer drug-induced osteoporosis (Endorsed by Endocrine Connections) | ECE2019
ea0063s10.2 | Cancer drug-induced osteoporosis (Endorsed by Endocrine Connections) | ECE2019
ea0063s10.3 | Cancer drug-induced osteoporosis (Endorsed by Endocrine Connections) | ECE2019